IL1B and neoplasm: In line with this notion, blockade of the ActRIIB receptor to inhibit Mstn signaling prevented cachexia in C26 tumor bearing mice, without affecting increased circulating levels of IL-6, TNF-α, and IL-1β (Zhou et al., 2010).